» Articles » PMID: 11960553

Biofilm Formation by Nontypeable Haemophilus Influenzae: Strain Variability, Outer Membrane Antigen Expression and Role of Pili

Overview
Journal BMC Microbiol
Publisher Biomed Central
Specialty Microbiology
Date 2002 Apr 19
PMID 11960553
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nontypeable Haemophilus influenzae is an important cause of otitis media in children and lower respiratory tract infection in adults with chronic obstructive pulmonary disease (COPD). Several lines of evidence suggest that the bacterium grows as a biofilm in the human respiratory tract.

Results: Fifteen clinical isolates from middle ear fluid of children with otitis media and 15 isolates from sputum of adults with COPD were studied in an in vitro assay of biofilm formation. Striking variability among isolates was observed in their ability to form biofilms. Analysis of cell envelopes revealed minimal differences in banding patterns in polyacrylamide gels, alteration of expression of an epitope on lipooligosaccharide, and preservation of expression of selected epitopes on outer membrane proteins P2, P5 and P6 in biofilms compared to planktonically grown cells. A pilus-deficient variant showed a marked impairment in biofilm formation compared to its isogenic parent.

Conclusions: Nontypeable H. influenzae forms biofilms in vitro. Clinical isolates show substantial variability in their ability to grow as biofilms. Three major outer membrane proteins (P2, P5 and P6) are expressed during growth as a biofilm. Expression of lipooligosaccharide is altered during growth as a biofilm compared to planktonic growth. Pili are important in biofilm formation. As the role of biofilms in human infection becomes better defined, characterization of biofilms may be important in understanding the pathogenesis of infection and immune response to nontypeable H. influenzae in children with otitis media and adults with COPD.

Citing Articles

Antimicrobial Peptide Recognition Motif of the Substrate Binding Protein SapA from Nontypeable .

Rivera K, Tanaka K, Buechel E, Origel Jr O, Harrison A, Mason K Biochemistry. 2024; 63(3):294-311.

PMID: 38189237 PMC: 10851439. DOI: 10.1021/acs.biochem.3c00562.


Adaptation of Nontypeable in Human Airways in COPD: Genome Rearrangements and Modulation of Expression of HMW1 and HMW2.

Murphy T, Kirkham C, DMello A, Sethi S, Pettigrew M, Tettelin H mBio. 2023; 14(2):e0014023.

PMID: 36927061 PMC: 10127715. DOI: 10.1128/mbio.00140-23.


Immortelle ( (Roth) G. Don) Essential Oil Showed Antibacterial and Biofilm Inhibitory Activity against Respiratory Tract Pathogens.

Balazs V, Filep R, Repas F, Kerekes E, Szabo P, Kocsis B Molecules. 2022; 27(17).

PMID: 36080283 PMC: 9457731. DOI: 10.3390/molecules27175518.


Nontypeable Haemophilus influenzae Redox Recycling of Protein Thiols Promotes Resistance to Oxidative Killing and Bacterial Survival in Biofilms in a Smoke-Related Infection Model.

Hunt B, Xu X, Gaggar A, Swords W mSphere. 2022; 7(1):e0084721.

PMID: 35044805 PMC: 8769201. DOI: 10.1128/msphere.00847-21.


The Formation of Biofilm and Bacteriology in Otitis Media with Effusion in Children: A Prospective Cross-Sectional Study.

Niedzielski A, Chmielik L, Stankiewicz T Int J Environ Res Public Health. 2021; 18(7).

PMID: 33808050 PMC: 8037871. DOI: 10.3390/ijerph18073555.


References
1.
Watnick P, Kolter R . Steps in the development of a Vibrio cholerae El Tor biofilm. Mol Microbiol. 1999; 34(3):586-95. PMC: 2860543. DOI: 10.1046/j.1365-2958.1999.01624.x. View

2.
Faden H . The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr. 2001; 160(7):407-13. DOI: 10.1007/s004310100754. View

3.
Murphy T . Haemophilus influenzae in chronic bronchitis. Semin Respir Infect. 2000; 15(1):41-51. DOI: 10.1053/srin.2000.0150041. View

4.
Klein J . Management of otitis media: 2000 and beyond. Pediatr Infect Dis J. 2000; 19(4):383-7. DOI: 10.1097/00006454-200004000-00034. View

5.
Murphy T . Bacterial otitis media: pathogenetic considerations. Pediatr Infect Dis J. 2000; 19(5 Suppl):S9-15; discussion S15-6. DOI: 10.1097/00006454-200005001-00003. View